Product Information
Cymbalta in GAD
Patients with generalized anxiety disorder (GAD) have excessive anxiety and worry, occuring more days than not for at least 6 months, about a number of events or activities. Patients with GAD often find it difficult to control their excessive anxiety or worry, and these symptoms are accompanied by at least 3 of the following: restlessness, becoming easily fatigued, difficulty concentrating, irritability, muscle tension, and disturbed sleep. These symptoms cause clinically significant distress or impairment with work, social, or other important areas of functioning.1
Cymbalta Demonstrated Relief for Patients With GAD
- Proven relief: In clinical trials, Cymbalta has significantly reduced anxious symptoms and improved functioning in patients with GAD2,3
- Safety and tolerability: Learn about treatment-emergent adverse events associated with Cymbalta in GAD
- Simplicity: Taken once daily, Cymbalta offers convenience and ease of use4
References:
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, Text Revision; Washington, DC; American Psychiatric Association; 2000.
- Data on file, Lilly Research Laboratories: CYM20070130A.
- Koponen H, et al. Poster presented at 26th annual conference of APAA; March 2006; Miami, Fla.
- Cymbalta full Prescribing Information, 2008.
Cymbalta for Fibromyalgia
Cymbalta is indicated for the management of fibromyalgia.
Formulary Access Finder
Cymbalta has been added to the Anthem Blue Cross Blue Shield National Preferred Formulary.
Get more information about the formulary access for Cymbalta. Download PDF files of insurance providers covering Cymbalta in your state.
Thought Leader Podcasts
Listen to peers and experts discuss the latest advances in diagnosis and treatment for MDD, GAD, DPNP, and fibromyalgia.
Listen to the podcasts now.







